In the BioHarmony Drug Report Database

"Preview" Icon

Nitric oxide

Genosyl, Inomax, INOmax (nitric oxide) is a small molecule pharmaceutical. Nitric oxide was first approved as Genosyl on 1999-12-23. It is used to treat newborn respiratory distress syndrome in the USA. It has been approved in Europe to treat pulmonary hypertension and respiratory insufficiency. It is known to target potassium channel subfamily K member 17 and potassium channel subfamily K member 16. Inomax’s patents are valid until 2036-05-03 (FDA).

 

Trade Name

 

INOmax
 

Common Name

 

nitric oxide
 

ChEMBL ID

 

CHEMBL1200689
 

Indication

 

newborn respiratory distress syndrome, pulmonary hypertension, respiratory insufficiency
 

Drug Class

 

Image (chem structure or protein)

Nitric oxide structure rendering